KOPRAN
Kopran Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in KOPRAN
Start SIPKopran Share Price
Kopran Investment Rating
-
Master Rating:
-
Kopran has an operating revenue of Rs. 512.32 Cr. on a trailing 12-month basis. An annual revenue de-growth of -4% needs improvement, Pre-tax margin of 17% is great, ROE of 14% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 49 which is a POOR score indicating inconsistency in earnings, a RS Rating of 5 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 124 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has remained stable in the last reported quarter. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 54 | 70 | 64 | 55 | 56 | 29 | 62 |
| Operating Expenses Qtr Cr | 48 | 64 | 58 | 51 | 52 | 29 | 55 |
| Operating Profit Qtr Cr | 6 | 6 | 7 | 3 | 5 | 1 | 7 |
| Depreciation Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest Qtr Cr | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 1 | 1 | 2 | 1 | 1 | 0 | 2 |
| Net Profit Qtr Cr | 18 | 4 | 5 | 2 | 4 | 1 | 6 |
Kopran Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 0
- 20 Day
- 162.98
- 50 Day
- 167.91
- 100 Day
- 182.65
- 200 Day
- 217.14
- 20 Day
- 163.76
- 50 Day
- 164.42
- 100 Day
- 178.69
- 200 Day
- 217.01
Kopran Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 167.62 |
| Second Resistance | 172.19 |
| Third Resistance | 175.17 |
| RSI | 47.14 |
| MFI | 69.36 |
| MACD Single Line | -2.45 |
| MACD | -1.67 |
| Support | |
|---|---|
| First Resistance | 160.07 |
| Second Resistance | 157.09 |
| Third Resistance | 152.52 |
Kopran Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 77,440 | 4,840,000 | 62.5 |
| Week | 246,006 | 9,840,232 | 40 |
| 1 Month | 350,438 | 13,236,027 | 37.77 |
| 6 Month | 165,414 | 7,661,965 | 46.32 |
Kopran Result Highlights
Kopran Synopsis
NSE-Medical-Diversified
Kopran Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 204.52 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2022. Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078.| Market Cap | 773 |
| Sales | 243 |
| Shares in Float | 2.70 |
| No of funds | 17 |
| Yield | 1.87 |
| Book Value | 2.04 |
| U/D Vol ratio | 1.7 |
| LTDebt / Equity | 1 |
| Alpha | -0.19 |
| Beta | 1.28 |
Kopran
| Owner Name | Sep-22 | Jun-22 | Mar-22 | Jan-22 |
|---|---|---|---|---|
| Promoters | 44.25% | 44.25% | 44.25% | |
| Mutual Funds | ||||
| Insurance Companies | 0.14% | 0.14% | 0.14% | |
| Foreign Portfolio Investors | 0.51% | 0.5% | 0.53% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 39.53% | 39.89% | 39.78% | |
| Others | 15.57% | 15.22% | 15.3% |
Kopran Management
| Name | Designation |
|---|---|
| Mr. Susheel G Somani | Chairman |
| Mr. Surendra Somani | Executive Vice Chairman |
| Mr. Adarsh Somani | Director |
| Mr. Varun Somani | Director |
| Dr. Siddhan Subramanian | Independent Director |
| Dr. Sunita Banerji | Independent Director |
| Mrs. Mamta Biyani | Independent Director |
| Mr. Narayan Atal | Independent Director |
Kopran Forecast
Price Estimates
Kopran Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2022-11-11 | Quarterly Results | |
| 2022-08-10 | Quarterly Results | |
| 2022-05-27 | Audited Results & Final Dividend | |
| 2022-02-03 | Quarterly Results | |
| 2021-10-27 | Quarterly Results |
Kopran FAQs
What is Share Price of Kopran ?
Kopran share price is ₹160 As on 01 December, 2022 | 04:51
What is the Market Cap of Kopran ?
The Market Cap of Kopran is ₹773.1 Cr As on 01 December, 2022 | 04:51
What is the P/E ratio of Kopran ?
The P/E ratio of Kopran is 15.5 As on 01 December, 2022 | 04:51
What is the PB ratio of Kopran ?
The PB ratio of Kopran is 1.8 As on 01 December, 2022 | 04:51